Lyra Therapeutics (LYRA) Profit After Tax (2021 - 2025)
Historic Profit After Tax for Lyra Therapeutics (LYRA) over the last 5 years, with Q3 2025 value amounting to -$6.0 million.
- Lyra Therapeutics' Profit After Tax rose 4959.99% to -$6.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$32.9 million, marking a year-over-year increase of 6625.39%. This contributed to the annual value of -$93.4 million for FY2024, which is 4901.91% down from last year.
- Per Lyra Therapeutics' latest filing, its Profit After Tax stood at -$6.0 million for Q3 2025, which was up 4959.99% from -$7.4 million recorded in Q2 2025.
- Over the past 5 years, Lyra Therapeutics' Profit After Tax peaked at -$6.0 million during Q3 2025, and registered a low of -$48.1 million during Q2 2024.
- In the last 5 years, Lyra Therapeutics' Profit After Tax had a median value of -$13.6 million in 2021 and averaged -$14.6 million.
- As far as peak fluctuations go, Lyra Therapeutics' Profit After Tax plummeted by 20817.65% in 2024, and later soared by 8454.84% in 2025.
- Lyra Therapeutics' Profit After Tax (Quarter) stood at -$13.6 million in 2021, then dropped by 4.73% to -$14.3 million in 2022, then dropped by 6.45% to -$15.2 million in 2023, then increased by 27.66% to -$11.0 million in 2024, then surged by 45.5% to -$6.0 million in 2025.
- Its Profit After Tax was -$6.0 million in Q3 2025, compared to -$7.4 million in Q2 2025 and -$8.5 million in Q1 2025.